{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:02:52Z","timestamp":1790694172213,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,10,9]],"date-time":"2017-10-09T00:00:00Z","timestamp":1507507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,10,9]],"date-time":"2017-10-09T00:00:00Z","timestamp":1507507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Many drugs commonly prescribed during pregnancy lack a fetal safety recommendation \u2013 called FDA \u2018category C\u2019 drugs. This study aims to classify these drugs into harmful and safe categories using knowledge gained from chemoinformatics (i.e., pharmacological similarity with drugs of known fetal effect) and empirical data (i.e., derived from Electronic Health Records). Our fetal loss cohort contains 14,922 affected and 33,043 unaffected pregnancies and our congenital anomalies cohort contains 5,658 affected and 31,240 unaffected infants. We trained a random forest to classify drugs of unknown pregnancy class into harmful or safe categories, focusing on two distinct outcomes: fetal loss and congenital anomalies. Our models achieved an out-of-bag accuracy of 91% for fetal loss and 87% for congenital anomalies outperforming null models. Fifty-seven \u2018category C\u2019 medications were classified as harmful for fetal loss and eleven for congenital anomalies. This includes medications with documented harmful effects, including naproxen, ibuprofen and rubella live vaccine. We also identified several novel drugs, e.g., haloperidol, that increased the risk of fetal loss. Our approach provides important information on the harmfulness of \u2018category C\u2019 drugs. This is needed, as no FDA recommendation exists for these drugs\u2019 fetal safety.<\/jats:p>","DOI":"10.1038\/s41598-017-12943-x","type":"journal-article","created":{"date-parts":[[2017,10,4]],"date-time":"2017-10-04T02:41:26Z","timestamp":1507084886000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Development of A Machine Learning Algorithm to Classify Drugs Of Unknown Fetal Effect"],"prefix":"10.1038","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8576-6408","authenticated-orcid":false,"given":"Mary Regina","family":"Boland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2355-2556","authenticated-orcid":false,"given":"Fernanda","family":"Polubriaginof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas P.","family":"Tatonetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,9]]},"reference":[{"key":"12943_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)09038-7","volume":"351","author":"A Dally","year":"1998","unstructured":"Dally, A. Thalidomide: was the tragedy preventable? The Lancet \n                           351, 1197 (1998).","journal-title":"The Lancet"},{"key":"12943_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/toxsci\/kfr088","volume":"122","author":"JH Kim","year":"2011","unstructured":"Kim, J. H. & Scialli, A. R. Thalidomide: the tragedy of birth defects and the effective treatment of disease. Toxicological Sciences \n                           122, 1\u20136 (2011).","journal-title":"Toxicological Sciences"},{"key":"12943_CR3","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/S0140-6736(62)92367-X","volume":"279","author":"R Smithells","year":"1962","unstructured":"Smithells, R. Thalidomide and malformations in Liverpool. The Lancet \n                           279, 1270\u20131273 (1962).","journal-title":"The Lancet"},{"key":"12943_CR4","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1002\/cpt1973144part2654","volume":"14","author":"RM Hill","year":"1973","unstructured":"Hill, R. M. Drugs ingested by pregnant women. Clinical Pharmacology & Therapeutics \n                           14, 654\u2013659 (1973).","journal-title":"Clinical Pharmacology & Therapeutics"},{"key":"12943_CR5","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s002280050608","volume":"55","author":"C Olesen","year":"1999","unstructured":"Olesen, C. et al. Drug use in first pregnancy and lactation: a population-based survey among Danish women. European journal of clinical pharmacology \n                           55, 139\u2013144 (1999).","journal-title":"European journal of clinical pharmacology"},{"key":"12943_CR6","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1136\/bmj.322.7281.266","volume":"322","author":"GL Nielsen","year":"2001","unstructured":"Nielsen, G. L., Sorensen, H. T., Larsen, H. & Pedersen, L. Risk of adverse birth outcome and miscarriage in pregnant users of non-steroidal anti-inflammatory drugs: population based observational study and case-control study. Bmj \n                           322, 266\u2013270 (2001).","journal-title":"Bmj"},{"key":"12943_CR7","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.ajog.2004.04.025","volume":"191","author":"SE Andrade","year":"2004","unstructured":"Andrade, S. E. et al. Prescription drug use in pregnancy. American journal of obstetrics and gynecology \n                           191, 398\u2013407 (2004).","journal-title":"American journal of obstetrics and gynecology"},{"key":"12943_CR8","doi-asserted-by":"publisher","unstructured":"Khare, R. et al. A longitudinal analysis of data quality in a large pediatric data research network. J Am Med Inform Assoc, doi:https:\/\/doi.org\/10.1093\/jamia\/ocx033 (2017).","DOI":"10.1093\/jamia\/ocx033"},{"key":"12943_CR9","volume":"19","author":"CfDY Cranor","year":"2008","unstructured":"Cranor, C. f. D. Y. Want to Bet Your Children\u2019s Health on Post-Market Harm Principles-An Argument for a Trespass or Permission Model for Regulating Toxicants. Vill. Envtl. LJ \n                           19, 251 (2008).","journal-title":"Vill. Envtl. LJ"},{"key":"12943_CR10","doi-asserted-by":"crossref","unstructured":"Muanda, F. T., Sheehy, O. & B\u00e9rard, A. Use of antibiotics during pregnancy and the risk of major congenital malformations: A population based cohort study. British Journal of Clinical Pharmacology (2017).","DOI":"10.1111\/bcp.13364"},{"key":"12943_CR11","doi-asserted-by":"crossref","unstructured":"Faherty, L. J. et al. Movement patterns in women at risk for perinatal depression: use of a mood-monitoring mobile application in pregnancy. Journal of the American Medical Informatics Association (2017).","DOI":"10.1093\/jamia\/ocx005"},{"key":"12943_CR12","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/jamia\/ocv109","volume":"23","author":"M Gordon","year":"2016","unstructured":"Gordon, M., Henderson, R., Holmes, J. H., Wolters, M. K. & Bennett, I. M. Participatory design of ehealth solutions for women from vulnerable populations with perinatal depression. Journal of the American Medical Informatics Association \n                           23, 105\u2013109 (2016).","journal-title":"Journal of the American Medical Informatics Association"},{"key":"12943_CR13","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1093\/jamia\/ocv046","volume":"22","author":"MR Boland","year":"2015","unstructured":"Boland, M. R., Shahn, Z., Madigan, D., Hripcsak, G. & Tatonetti, N. P. Birth month affects lifetime disease risk: a phenome-wide method. Journal of the American Medical Informatics Association \n                           22, 1042\u20131053 (2015).","journal-title":"Journal of the American Medical Informatics Association"},{"key":"12943_CR14","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1136\/jamia.1994.95153433","volume":"1","author":"LK Woolery","year":"1994","unstructured":"Woolery, L. K. & Grzymala-Busse, J. Machine learning for an expert system to predict preterm birth risk. Journal of the American Medical Informatics Association \n                           1, 439\u2013446 (1994).","journal-title":"Journal of the American Medical Informatics Association"},{"key":"12943_CR15","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1136\/amiajnl-2013-001854","volume":"21","author":"S Mani","year":"2014","unstructured":"Mani, S. et al. Medical decision support using machine learning for early detection of late-onset neonatal sepsis. Journal of the American Medical Informatics Association \n                           21, 326\u2013336, https:\/\/doi.org\/10.1136\/amiajnl-2013-001854 (2014).","journal-title":"Journal of the American Medical Informatics Association"},{"key":"12943_CR16","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1093\/jamia\/ocw113","volume":"24","author":"CD Meyerhoefer","year":"2017","unstructured":"Meyerhoefer, C. D. et al. A mixed methods study of clinical information availability in obstetric triage and prenatal offices. Journal of the American Medical Informatics Association \n                           24, e87\u2013e94 (2017).","journal-title":"Journal of the American Medical Informatics Association"},{"key":"12943_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0010-7824(98)00150-4","volume":"59","author":"EA Schaff","year":"1999","unstructured":"Schaff, E. A. et al. Low-dose mifepristone 200\u2009MG and vaginal misoprostol for abortion. Contraception \n                           59, 1\u20136 (1999).","journal-title":"Contraception"},{"key":"12943_CR18","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/S0890-6238(01)00137-X","volume":"15","author":"A Ericson","year":"2001","unstructured":"Ericson, A. & K\u00e4ll\u00e9n, B. A. J. Nonsteroidal anti-inflammatory drugs in early pregnancy. Reproductive Toxicology \n                           15, 371\u2013375, https:\/\/doi.org\/10.1016\/S0890-6238(01)00137-X (2001).","journal-title":"Reproductive Toxicology"},{"key":"12943_CR19","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/bdrb.20085","volume":"77","author":"B Ofori","year":"2006","unstructured":"Ofori, B., Oraichi, D., Blais, L., Rey, E. & B\u00e9rard, A. Risk of congenital anomalies in pregnant users of non\u2010steroidal anti\u2010inflammatory drugs: A nested case\u2010control study. Birth Defects Research Part B: Developmental and Reproductive Toxicology \n                           77, 268\u2013279 (2006).","journal-title":"Birth Defects Research Part B: Developmental and Reproductive Toxicology"},{"key":"12943_CR20","doi-asserted-by":"publisher","first-page":"228.e221","DOI":"10.1016\/j.ajog.2011.11.019","volume":"206","author":"RK Hernandez","year":"2012","unstructured":"Hernandez, R. K., Werler, M. M., Romitti, P., Sun, L. & Anderka, M. Nonsteroidal antiinflammatory drug use among women and the risk of birth defects. American Journal of Obstetrics and Gynecology \n                           206, 228.e221\u2013228.e228, https:\/\/doi.org\/10.1016\/j.ajog.2011.11.019 (2012).","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"12943_CR21","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1213\/ANE.0b013e31828a4b54","volume":"116","author":"M Bloor","year":"2013","unstructured":"Bloor, M. & Paech, M. Nonsteroidal anti-inflammatory drugs during pregnancy and the initiation of lactation. Anesthesia & Analgesia \n                           116, 1063\u20131075 (2013).","journal-title":"Anesthesia & Analgesia"},{"key":"12943_CR22","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1053\/j.nainr.2008.12.006","volume":"9","author":"M Torres","year":"2009","unstructured":"Torres, M. & Nieves, J. A. Progress in congenital cardiac care for newborns and infants: the emerging role of \u201coff-label\u201d medications. Newborn and Infant Nursing Reviews \n                           9, 18\u201330 (2009).","journal-title":"Newborn and Infant Nursing Reviews"},{"key":"12943_CR23","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1177\/106002809402800901","volume":"28","author":"ML Buck","year":"1994","unstructured":"Buck, M. L. & Rudis, M. Clinical experience with ketorolac in children. Annals of Pharmacotherapy \n                           28, 1009\u20131013 (1994).","journal-title":"Annals of Pharmacotherapy"},{"key":"12943_CR24","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1111\/j.1460-9592.2005.01806.x","volume":"16","author":"BS Moffett","year":"2006","unstructured":"Moffett, B. S., Wann, T. I., Carberry, K. E. & Mott, A. R. Safety of ketorolac in neonates and infants after cardiac surgery. Pediatric Anesthesia \n                           16, 424\u2013428 (2006).","journal-title":"Pediatric Anesthesia"},{"key":"12943_CR25","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1001\/archopht.1967.00980020436004","volume":"77","author":"LZ Cooper","year":"1967","unstructured":"Cooper, L. Z. & Krugman, S. Clinical manifestations of postnatal and congenital rubella. Archives of Ophthalmology \n                           77, 434\u2013439 (1967).","journal-title":"Archives of Ophthalmology"},{"key":"12943_CR26","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/(SICI)1096-9926(199807)58:1<13::AID-TERA5>3.0.CO;2-2","volume":"58","author":"WS Webster","year":"1998","unstructured":"Webster, W. S. Teratogen update: congenital rubella. Teratology \n                           58, 13\u201323 (1998).","journal-title":"Teratology"},{"key":"12943_CR27","doi-asserted-by":"crossref","first-page":"201","DOI":"10.5694\/j.1326-5377.1943.tb88413.x","volume":"2","author":"C Swan","year":"1943","unstructured":"Swan, C., Tostevin, A., Moore, B., Mayo, H. & Black, G. B. Congenital Defects in Infants following Infectious Diseases during Pregnancy. With special reference to the Relationship between German Measles and Cataract, Deaf-Mutism, Heart Disease and Microcephaly, and to the Period of Pregnancy in which the Occurrence of Rubella is followed by Congenital Abnormalities. Medical journal of Australia \n                           2, 201\u2013210 (1943).","journal-title":"Medical journal of Australia"},{"key":"12943_CR28","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1001\/jama.1965.03080100061013","volume":"191","author":"AJ Rudolph","year":"1965","unstructured":"Rudolph, A. J. et al. Transplacental rubella infection in newly born infants. JAMA \n                           191, 843\u2013845 (1965).","journal-title":"JAMA"},{"key":"12943_CR29","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1001\/jama.1965.03090250011002","volume":"194","author":"RL Naeye","year":"1965","unstructured":"Naeye, R. L. & Blanc, W. Pathogenesis of congenital rubella. JAMA \n                           194, 1277\u20131283, https:\/\/doi.org\/10.1001\/jama.1965.03090250011002 (1965).","journal-title":"JAMA"},{"key":"12943_CR30","volume":"54","author":"AM Ergenoglu","year":"2012","unstructured":"Ergenoglu, A. M. et al. Rubella vaccination during the preconception period or in pregnancy and perinatal and fetal outcomes. The Turkish journal of pediatrics \n                           54, 230 (2012).","journal-title":"The Turkish journal of pediatrics"},{"key":"12943_CR31","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1002\/bdra.23064","volume":"94","author":"MC Brennan","year":"2012","unstructured":"Brennan, M. C. & Rayburn, W. F. Counseling about risks of congenital anomalies from prescription opioids. Birth Defects Research Part A: Clinical and Molecular Teratology \n                           94, 620\u2013625 (2012).","journal-title":"Birth Defects Research Part A: Clinical and Molecular Teratology"},{"key":"12943_CR32","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1111\/dsu.12322","volume":"39","author":"KC Lee","year":"2013","unstructured":"Lee, K. C., Korgavkar, K., Dufresne, R. G. & Higgins, H. W. Safety of cosmetic dermatologic procedures during pregnancy. Dermatologic Surgery \n                           39, 1573\u20131586 (2013).","journal-title":"Dermatologic Surgery"},{"key":"12943_CR33","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1056\/NEJM196009012630908","volume":"263","author":"HdC Peterson","year":"1960","unstructured":"Peterson, H. d. C. Acquired methemoglobinemia in an infant due to benzocaine suppository. New England Journal of Medicine \n                           263, 454\u2013455 (1960).","journal-title":"New England Journal of Medicine"},{"key":"12943_CR34","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/tpj.2016.48","volume":"16","author":"M Boland","year":"2016","unstructured":"Boland, M. & Tatonetti, N. Investigation of 7-dehydrocholesterol reductase pathway to elucidate off-target prenatal effects of pharmaceuticals: a systematic review. The pharmacogenomics journal \n                           16, 411\u2013429 (2016).","journal-title":"The pharmacogenomics journal"},{"key":"12943_CR35","doi-asserted-by":"publisher","unstructured":"Korade, \u017d. et al. Effect of psychotropic drug treatment on sterol metabolism. Schizophrenia Research, doi:https:\/\/doi.org\/10.1016\/j.schres.2017.02.001 (2017).","DOI":"10.1016\/j.schres.2017.02.001"},{"key":"12943_CR36","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/sj.clpt.6100100","volume":"81","author":"Y Goh","year":"2007","unstructured":"Goh, Y., Bollano, E., Einarson, T. & Koren, G. Prenatal multivitamin supplementation and rates of pediatric cancers: a meta\u2010analysis. Clinical Pharmacology & Therapeutics \n                           81, 685\u2013691 (2007).","journal-title":"Clinical Pharmacology & Therapeutics"},{"key":"12943_CR37","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ejmhg.2016.04.001","volume":"18","author":"T Sunitha","year":"2017","unstructured":"Sunitha, T. et al. Risk factors for congenital anomalies in high risk pregnant women: A large study from South India. Egyptian Journal of Medical Human Genetics \n                           18, 79\u201385, https:\/\/doi.org\/10.1016\/j.ejmhg.2016.04.001 (2017).","journal-title":"Egyptian Journal of Medical Human Genetics"},{"key":"12943_CR38","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.ajog.2003.12.038","volume":"191","author":"P Rozenberg","year":"2004","unstructured":"Rozenberg, P. et al. A randomized trial that compared intravaginal misoprostol and dinoprostone vaginal insert in pregnancies at high risk of fetal distress. American Journal of Obstetrics and Gynecology \n                           191, 247\u2013253, https:\/\/doi.org\/10.1016\/j.ajog.2003.12.038 (2004).","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"12943_CR39","doi-asserted-by":"publisher","first-page":"i81","DOI":"10.1136\/amiajnl-2010-000057","volume":"18","author":"BL Strom","year":"2011","unstructured":"Strom, B. L. et al. Detecting pregnancy use of non-hormonal category X medications in electronic medical records. Journal of the American Medical Informatics Association \n                           18, i81\u2013i86, https:\/\/doi.org\/10.1136\/amiajnl-2010-000057 (2011).","journal-title":"Journal of the American Medical Informatics Association"},{"key":"12943_CR40","unstructured":"NYSDOH. Congenital Malformations Registry - Summary Report. Appendix 1: Classification of Codes. https:\/\/www.health.ny.gov\/diseases\/congenital_malformations\/2002_2004\/appendices.htm Accessed on 11\/30\/2016 (2007)."},{"key":"12943_CR41","doi-asserted-by":"crossref","unstructured":"Stevenson, R. E., Solomon, B. D. & Everman, D. B. Human malformations and related anomalies. (Oxford University Press, 2015).","DOI":"10.1093\/med\/9780199386031.001.0001"},{"key":"12943_CR42","unstructured":"CDC, Ventura, S. J., Curtin, S. C., Abma, J. C. & Henshaw, S. K. Estimated Pregnancy Rates and Rates of Pregnancy Outcomes for the United States, 1990\u20132008. National Vital Statistics Reports https:\/\/www.cdc.gov\/nchs\/data\/nvsr\/nvsr60\/nvsr60_07.pdf (2012)."},{"key":"12943_CR43","unstructured":"UpToDate. Accessed in December, 2016 and January 2017 uptodate.com (2017)."},{"key":"12943_CR44","unstructured":"Drugs.com. Accessed in December, 2016 and January 2017 drugs.com (2017)."},{"key":"12943_CR45","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1345\/aph.1A034","volume":"35","author":"LA Boothby","year":"2001","unstructured":"Boothby, L. A. & Doering, P. L. FDA labeling system for drugs in pregnancy. Annals of Pharmacotherapy \n                           35, 1485\u20131489 (2001).","journal-title":"Annals of Pharmacotherapy"},{"key":"12943_CR46","unstructured":"CDC. Measuring Gestational Age in Vital Statistics Data: Transitioning to the Obstetric Estimate. National Vital Statistics Reports http:\/\/www.cdc.gov\/nchs\/data\/nvsr\/nvsr64\/nvsr64_05.pdf (2015)."},{"key":"12943_CR47","unstructured":"CDC. CDCs Abortion Surveillance System FAQs: Abortion Surveillance\u2014Findings and Reports. Reproductive Health https:\/\/www.cdc.gov\/reproductivehealth\/data_stats\/abortion.htm (2017)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-12943-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-12943-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-12943-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T06:45:34Z","timestamp":1671777934000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-12943-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,9]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["12943"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-12943-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,9]]},"assertion":[{"value":"5 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"12839"}}